Showing results (211-220 of 286) with videos related to

Sort By:
Pageof 29
Molecular Cancer Therapeutics|March 31, 2019
Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient MiceRong Wang, Tadaaki Yamada, Sachiko Arai, et al.
Anticancer Research|December 3, 2024
Analysis of Methylation of Tumor-suppressive miRNAs and <i>KRAS/TP53</i> Mutations in Pancreatic JuiceKoushiro Ohtsubo, Kunio Miyake, Shigeki Sato, et al.
Cancer Medicine|November 11, 2017
In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugsKenji Kita, Sachiko Arai, Akihiro Nishiyama, et al.
ACS Nano|January 20, 2026
High-Speed Atomic Force Microscopy Reveals Disordered Region-Mediated Structural Plasticity of Anaplastic Lymphoma Kinase Fusion Proteins Induced by InhibitorsXujun Han, Noriyuki Kodera, Neval Yilmaz, et al.
The Journal of Medical Investigation : JMI|September 29, 2017
Phase I/II study of alectinib in lung cancer with RET fusion gene: study protocolShinji Takeuchi, Toshinori Murayama, Kenichi Yoshimura, et al.
Internal Medicine (Tokyo, Japan)|September 1, 2020
Multiple Malignant Lymphomas of the Bile Duct Developing after Spontaneous Regression of an Autoimmune Pancreatitis-like MassKoushiro Ohtsubo, Kaname Yamashita, Naohiro Yanagimura, et al.
Plos One|May 22, 2013
mTOR inhibitors control the growth of EGFR mutant lung cancer even after acquiring resistance by HGFDaisuke Ishikawa, Shinji Takeuchi, Takayuki Nakagawa, et al.
Clinical Lung Cancer|January 13, 2023
Epidemiological and Therapeutic Analyses in Lung Cancer Patients Over 80 Years Old in the Hokushin Region: A Retrospective Hospital Administrative Database StudyTomonobu Koizumi, Yoshikazu Nishino, Tomoya Takiguchi, et al.
Anticancer Research|October 2, 2019
Aberrant Methylation of Tumor Suppressive miRNAs in Bile from Patients With Pancreaticobiliary DiseasesKoushiro Ohtsubo, Kunio Miyake, Sachiko Arai, et al.
Cancer Science|April 1, 2022
Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cellsChiaki Suzuki, Akihiro Nishiyama, Sachiko Arai, et al.
Pageof 29